Emmanuel Prata de Souza
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Emmanuel Prata de Souza has a total of 31 co-authors. Here are the top co-authors by number of shared publications:
- Alexandre Holanda Sampaio
Laboratório de Biotecnologia Marinha—BioMar-Lab, Departamento de Engenharia de Pesca, Universidade Federal do Ceará, Campus do Pici s/n, bloco 871, Fortaleza 60440-970, CE, Brazil
1 shared publication - Ana Luiza Viana Pequeno
Department of Morphology, Faculty of Medicine, Federal University of Ceará, Fortaleza, CE 60430-170, Brazil
1 shared publication - Ana Maria Sampaio Assreuy
Laboratório de Fisio-Farmacologia da Inflamação (LAFFIN), Instituto Superior de Ciências Biomédicas, Universidade Estadual do Ceará, Av. Dr. Silas Munguba 1700, Fortaleza, CE, 60714-903, Brazil.
1 shared publication - Angeline M. H. P. Silva
Department of Morphology, Faculty of Medicine, Federal University of Ceará, Fortaleza, CE 60430-170, Brazil
1 shared publication - Beatriz T Freitas
Departamento de Biologia, Universidade Regional do Cariri, Ceará, Brazil
1 shared publication - Benildo Sousa Cavada
BioMol-Lab, Department of Biochemistry and Molecular Biology, Federal University of Ceará, Fortaleza 60440-970, Ceará, Brazil
1 shared publication
Latest Publications
- Open Access
- 5 May 2026
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 368, 121817
The anti-inflammatory effect of the aqueous fraction from Dacryodes kukachkana extract involves the L-arginine/NO/cGMP pathway
- 5 May 2026
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 368, 121817
Open AccessThe anti-inflammatory effect of the aqueous fraction from Dacryodes kukachkana extract involves the L-arginine/NO/cGMP pathway
- Open Access
- 3 November 2020
- Published by MDPI AG in Pharmaceuticals
- Vol. 13 (11) , 361
The Alpha-Lipoic Acid Improves Survival and Prevents Irinotecan-Induced Inflammation and Intestinal Dysmotility in Mice
Irinotecan, an anticancer drug, induces diarrhea and intestinal inflammation, resulting in an increase in the cost of care and in treatment delays. In this study, we investigated whether alpha-lipoic acid (α-LA) could improve irinotecan-mediated intestinal inflammation, diarrhea and dysmotility. Intestinal mucositis was induced by irinotecan injection (75 mg/kg, i.p., for 4 days) in Swiss mice. α-LA (50, 100 or 200 mg/kg, gavage) was administered daily 1 h before the injection of irinotecan. Duodenum tissues were obtained for inflammation and proliferation analysis. The outcomes: diarrhea, intestinal dysmotility, weight body loss and survival were evaluated. Compared with the control condition, irinotecan diminished (p < 0.05) intestinal villus height, caused a loss of crypt integrity and intense inflammatory cell infiltration, increased myeloperoxidase (MPO), IL-6 and IL-1β levels and decreased reduced glutathione (GSH) levels in duodenum segments and increased gastric retention and decreased liquid retention in the medial intestinal segment, resulting in increased intestinal transit, severe diarrhea and reduced survival (approximately 72%). Furthermore, α-LA (200 mg/kg) pretreatment ameliorated (p < 0.05) these irinotecan-induced effects. Our findings show that α-LA reduced irinotecan-induced inflammation, intestinal dysmotility and diarrhea, resulting in improved survival. α-LA may be a useful therapeutic agent for the treatment of gut dysmotility in patients with intestinal mucositis associated with irinotecan treatment.
- 3 November 2020
- Published by MDPI AG in Pharmaceuticals
- Vol. 13 (11) , 361
Open AccessThe Alpha-Lipoic Acid Improves Survival and Prevents Irinotecan-Induced Inflammation and Intestinal Dysmotility in Mice
Irinotecan, an anticancer drug, induces diarrhea and intestinal inflammation, resulting in an increase in the cost of care and in treatment delays. In this study, we investigated whether alpha-lipoic acid (α-LA) could improve irinotecan-mediated intestinal inflammation, diarrhea and dysmotility. Intestinal mucositis was induced by irinotecan injection (75 mg/kg, i.p., for 4 days) in Swiss mice. α-LA (50, 100 or 200 mg/kg, gavage) was administered daily 1 h before the injection of irinotecan. Duodenum tissues were obtained for inflammation and proliferation analysis. The outcomes: diarrhea, intestinal dysmotility, weight body loss and survival were evaluated. Compared with the control condition, irinotecan diminished (p < 0.05) intestinal villus height, caused a loss of crypt integrity and intense inflammatory cell infiltration, increased myeloperoxidase (MPO), IL-6 and IL-1β levels and decreased reduced glutathione (GSH) levels in duodenum segments and increased gastric retention and decreased liquid retention in the medial intestinal segment, resulting in increased intestinal transit, severe diarrhea and reduced survival (approximately 72%). Furthermore, α-LA (200 mg/kg) pretreatment ameliorated (p < 0.05) these irinotecan-induced effects. Our findings show that α-LA reduced irinotecan-induced inflammation, intestinal dysmotility and diarrhea, resulting in improved survival. α-LA may be a useful therapeutic agent for the treatment of gut dysmotility in patients with intestinal mucositis associated with irinotecan treatment.
- Open Access
- 2 August 2007
- Published by Springer Nature in BMC Structural Biology
- Vol. 7 (1) , 52
Structure of a lectin from Canavalia gladiata seeds: new structural insights for old molecules
Lectins are mainly described as simple carbohydrate-binding proteins. Previous studies have tried to identify other binding sites, which possible recognize plant hormones, secondary metabolites, and isolated amino acid residues. We report the crystal structure of a lectin isolated from Canavalia gladiata seeds (CGL), describing a new binding pocket, which may be related to pathogen resistance activity in ConA-like lectins; a site where a non-protein amino-acid, α-aminobutyric acid (Abu), is bound.
- 2 August 2007
- Published by Springer Nature in BMC Structural Biology
- Vol. 7 (1) , 52
Open AccessStructure of a lectin from Canavalia gladiata seeds: new structural insights for old molecules
Lectins are mainly described as simple carbohydrate-binding proteins. Previous studies have tried to identify other binding sites, which possible recognize plant hormones, secondary metabolites, and isolated amino acid residues. We report the crystal structure of a lectin isolated from Canavalia gladiata seeds (CGL), describing a new binding pocket, which may be related to pathogen resistance activity in ConA-like lectins; a site where a non-protein amino-acid, α-aminobutyric acid (Abu), is bound.